| # | Drug | Count |
|---|---|---|
| 0 | NIRAPARIB | 85 |
| 1 | RIBOCICLIB | 59 |
| 2 | FULVESTRANT | 36 |
| 3 | LETROZOLE | 35 |
| 4 | CYCLOPHOSPHAMIDE | 30 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 30 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 30 |
| 7 | RITUXIMAB | 30 |
| 8 | PALBOCICLIB | 29 |
| 9 | ASPIRIN | 28 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLOTUFOLASTAT F-18 | 14 | 0.2857 |
| 1 | FLUCICLOVINE F-18 | 22 | 0.2157 |
| 2 | KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE | 1 | 0.0222 |
| 3 | FLORBETAPIR F 18 | 2 | 0.0174 |
| 4 | NIRAPARIB TOSYLATE MONOHYDRATE AND ABIRATERONE ACETATE | 1 | 0.0161 |
| 5 | FLUDEOXYGLUCOSE F-18 | 4 | 0.0142 |
| 6 | RUBIDIUM CHLORIDE RB-82 | 1 | 0.0086 |
| 7 | TROLAMINE SALICYLATE | 1 | 0.0052 |
| 8 | NIRAPARIB | 85 | 0.0038 |
| 9 | ELACESTRANT | 21 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 67 |
| 1 | Corticosteroid [EPC] | 64 |
| 2 | Estrogen Receptor Antagonist [EPC] | 57 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 46 |
| 4 | Aromatase Inhibitor [EPC] | 45 |
| 5 | Radioactive Diagnostic Agent [EPC] | 42 |
| 6 | Alkylating Drug [EPC] | 33 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 32 |
| 8 | Platinum-based Drug [EPC] | 32 |
| 9 | Benzodiazepine [EPC] | 31 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Radioactive Diagnostic Agent [EPC] | 42 | 0.0134 |
| 1 | Estrogen Receptor Antagonist [EPC] | 57 | 0.0014 |
| 2 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 3 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 4 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 5 | Aromatase Inhibitor [EPC] | 45 | 0.0004 |
| 6 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 7 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 8 | CD30-directed Immunoconjugate [EPC] | 3 | 0.0003 |
| 9 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |